Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-13 4:49 pm Purchase | 13G | GENOCEA BIOSCIENCES INC NE GNCA | UBS OCONNOR LLC | 1,769,460 6.3% | 1,769,460 (New Position) | View |
| 2020-02-13 4:45 pm Purchase | 13G | FINSERV ACQUISITION CORP CLASS FSRV | UBS OCONNOR LLC | 1,800,000 7% | 1,800,000 (New Position) | View |
| 2020-02-13 4:43 pm Purchase | 13G | EXPERIENCE INVT CORP COM EXPC | UBS OCONNOR LLC | 2,675,000 9.7% | 2,675,000 (New Position) | View |
| 2020-02-13 4:40 pm Purchase | 13G | DIAMONDPEAK HLDGS CORP COM CL DPHC | UBS OCONNOR LLC | 2,150,000 7.7% | 2,150,000 (New Position) | View |
| 2020-02-13 4:37 pm Purchase | 13G | CIIG MERGER CORP CIIC | UBS OCONNOR LLC | 1,800,000 7% | 1,800,000 (New Position) | View |
| 2020-02-13 4:34 pm Purchase | 13G | CHP MERGER CORP CHPM | UBS OCONNOR LLC | 2,450,000 8.2% | 2,450,000 (New Position) | View |
| 2020-02-13 4:31 pm Purchase | 13G | APEX TECHNOLOGY ACQUISITION CO APXT | UBS OCONNOR LLC | 2,500,000 7% | 2,500,000 (New Position) | View |
| 2020-02-13 4:29 pm Purchase | 13G | AMPLITUDE HEALTHCARE ACQUISITI AMHC | UBS OCONNOR LLC | 550,000 5.5% | 550,000 (New Position) | View |
| 2020-02-13 4:26 pm Purchase | 13G | ACT II GLOBAL ACQUISITION CORP ACTT | UBS OCONNOR LLC | 1,733,444 5.8% | 1,733,444 (New Position) | View |
| 2020-02-13 4:22 pm Purchase | 13G | ACAMAR PARTNERS ACQUISITION CO ACAM | UBS OCONNOR LLC | 2,074,000 6.8% | 2,074,000 (New Position) | View |
| 2020-02-13 4:18 pm Purchase | 13G | PROTALIX BIOTHERAPEUTICS INC C PLX | UBS OCONNOR LLC | 8,000,000 5.1% | 8,000,000 (New Position) | View |
| 2020-02-13 4:17 pm Purchase | 13G | PROVIDENCE ACQUISITION COR NPA | UBS OCONNOR LLC | 2,277,000 9.9% | 2,277,000 (New Position) | View |